Deltex Medical has raised £1.4m in new capital to launch, market and commercialise the next generation TrueVue haemodynamic monitor as well as a new non-invasive ultrasound probe. Each product has a significant potential to accelerate revenue growth for the Company, from a capital replacement perspective, but also to grow the addressable market and raise market penetration
10 Feb 2022
Deltex Medical* - Accelerating Product Launch
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Deltex Medical* - Accelerating Product Launch
Deltex Medical Group plc (DEMG:LON) | 0.1 0 4.0% | Mkt Cap: 2.46m
- Published:
10 Feb 2022 -
Author:
Andrew Simms -
Pages:
9
Deltex Medical has raised £1.4m in new capital to launch, market and commercialise the next generation TrueVue haemodynamic monitor as well as a new non-invasive ultrasound probe. Each product has a significant potential to accelerate revenue growth for the Company, from a capital replacement perspective, but also to grow the addressable market and raise market penetration